BioMed e-Series: 18 Volumes – electronic Table of Contents (eTOCs) of each Volume
Curator: Aviva Lev-Ari, PhD, RN
CLICK on the RED Link to review eTOCs of each Volume on LinkedIn
CLICK on the BLUE Link to review eTOCs of each Volume on Amazon.com
CLICK on the GREEN Link to review DETAILED eTOCs of each Volume
on https://pharmaceuticalintelligence.com/
Series A: e-Books on Cardiovascular Diseases
Series Content Consultant: Justin D Pearlman, MD, PhD, FACC
Volume 1,2,3,4,5,6
Volume 1: Perspectives on Nitric Oxide in Disease Mechanisms
http://www.amazon.com/dp/B00DINFFYC
https://www.linkedin.com/pulse/perspectives-nitric-oxide-disease-mechanisms-table-aviva/
Volume 2: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation
http://www.amazon.com/dp/B018Q5MCN8
https://www.linkedin.com/pulse/cardiovascular-original-research-cases-methodology-aviva/
Volume 3: Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics
http://www.amazon.com/dp/B018PNHJ84
https://www.linkedin.com/pulse/etiologies-cardiovascular-diseases-epigenetics-lev-ari-phd-rn/
Volume 4: Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases
http://www.amazon.com/dp/B019UM909A
https://www.linkedin.com/pulse/regenerative-translational-medicine-therapeutics-lev-ari-phd-rn/
https://www.amazon.com/dp/B07MGSFDWR
https://www.linkedin.com/post/edit/pharmacological-agents-treatment-cardiovascular-book-aviva
https://www.amazon.com/dp/B07MKHDBHF
https://www.linkedin.com/pulse/interventional-cardiology-disease-diagnosis-cardiac-lev-ari-phd-rn/
Series B: Frontiers in Genomics Research
Series Content Consultant: Prof. Marcus Feldman, Stanford University
Volume 1: Genomics Orientations for Personalized Medicine
http://www.amazon.com/dp/B018DHBUO6
Volume 2: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology
https://www.amazon.com/dp/B08385KF87
- Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology
Series C: e-Books on Cancer & Oncology
Series Content Consultant: Larry H Bernstein, MD, FCAP
Volume 1: Cancer Biology and Genomics for Disease Diagnosis
http://www.amazon.com/dp/B013RVYR2K
https://www.linkedin.com/pulse/cancer-biology-genomics-disease-diagnosis-table-lev-ari-phd-rn/
Volume 2: Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery
http://www.amazon.com/dp/B071VQ6YYK
Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases &
Genomic Endocrinology
Series Content Consultant: Larry H Bernstein, MD, FCAP
Volume 1: Metabolic Genomics & Pharmaceutics electronic Table of Contents
http://www.amazon.com/dp/B012BB0ZF0
https://www.linkedin.com/pulse/metabolic-genomics-pharmaceutics-electronic-table-lev-ari-phd-rn/
Volume 2 & Volume 3:
https://www.amazon.com/dp/B075CXHY1B
Volume 2: Infectious Diseases and Therapeutics e-Table of Contents, Volume 2
https://www.linkedin.com/pulse/infectious-diseases-therapeutics-e-table-contents-2-lev-ari-phd-rn/
Volume 3: The Immune System and Therapeutics
Volume 4: Human Reproductive System, Genomic Endocrinology and Cancer Types
http://www.amazon.com/dp/B08VTFWVKM
https://www.linkedin.com/pulse/human-reproductive-system-genomic-endocrinology-types-aviva/
Series E: Patient-Centered Medicine
Series Content Consultant: Larry H Bernstein, MD, FCAP
Volume 1:
The VOICES of Patients, Hospitals CEOs, Health Care Providers, Caregivers and Families
https://www.amazon.com/dp/B076HGB6MZ
https://www.linkedin.com/pulse/voices-patients-hospitals-ceos-health-care-providers-aviva/
Volume 2:
Medical Scientific Discoveries for the 21st Century & Interviews with Scientific Leaders
https://www.amazon.com/dp/B078313281
https://www.linkedin.com/pulse/medical-scientific-discoveries-21st-century-leaders-lev-ari-phd-rn/
- Volume Two: Medical Scientific Discoveries for the 21st Century & Interviews with Scientific Leaders
Volume 3:
Milestones in Physiology – Discoveries in Medicine, Genomics and Therapeutics Patient-centric Perspective
http://www.amazon.com/dp/B019VH97LU
https://www.linkedin.com/pulse/milestones-physiology-discoveries-medicine-genomics-aviva/
Volume 4
Medical 3D BioPrinting – The Revolution in Medicine -Technologies for Patient-centered Medicine: From R&D in Biologics to New Medical Devices
https://www.amazon.com/dp/B078QVDV2W
BioMed e-Series
https://pharmaceuticalintelligence.com/biomed-e-books/
BioMed e-Series
- Series A: e-Books on Cardiovascular Diseases
- Series B: Frontiers in Genomics Research
- Series C: e-Books on Cancer & Oncology
- Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases and Genomic Endocrinology
- Series E: Patient-Centered Medicine
WE ARE ON AMAZON.COM with 18 Books in Medicine
https://lnkd.in/ekWGNqA
http://www.amazon.com/dp/B00DINFFYC
http://www.amazon.com/dp/B018Q5MCN8
http://www.amazon.com/dp/B018PNHJ84
http://www.amazon.com/dp/B018DHBUO6
http://www.amazon.com/dp/B013RVYR2K
http://www.amazon.com/dp/B012BB0ZF0
http://www.amazon.com/dp/B019UM909A
http://www.amazon.com/dp/B019VH97LU
http://www.amazon.com/dp/B071VQ6YYK
https://www.amazon.com/dp/B075CXHY1B
https://www.amazon.com/dp/B076HGB6MZ
https://www.amazon.com/dp/B078313281
https://www.amazon.com/dp/B078QVDV2W
https://www.amazon.com/dp/B07MGSFDWR
https://www.amazon.com/dp/B07MKHDBHF
https://www.amazon.com/dp/B08385KF87
http://www.amazon.com/dp/B08VTFWVKM
This is very insightful. There is no doubt that there is the bias you refer to. 42 years ago, when I was postdocing in biochemistry/enzymology before completing my residency in pathology, I knew that there were very influential mambers of the faculty, who also had large programs, and attracted exceptional students. My mentor, it was said (although he was a great writer), could draft a project on toilet paper and call the NIH. It can’t be true, but it was a time in our history preceding a great explosion. It is bizarre for me to read now about eNOS and iNOS, and about CaMKII-á, â, ã, ä – isoenzymes. They were overlooked during the search for the genome, so intermediary metabolism took a back seat. But the work on protein conformation, and on the mechanism of action of enzymes and ligand and coenzyme was just out there, and became more important with the research on signaling pathways. The work on the mechanism of pyridine nucleotide isoenzymes preceded the work by Burton Sobel on the MB isoenzyme in heart. The Vietnam War cut into the funding, and it has actually declined linearly since.
A few years later, I was an Associate Professor at a new Medical School and I submitted a proposal that was reviewed by the Chairman of Pharmacology, who was a former Director of NSF. He thought it was good enough. I was a pathologist and it went to a Biochemistry Review Committee. It was approved, but not funded. The verdict was that I would not be able to carry out the studies needed, and they would have approached it differently. A thousand young investigators are out there now with similar letters. I was told that the Department Chairmen have to build up their faculty. It’s harder now than then. So I filed for and received 3 patents based on my work at the suggestion of my brother-in-law. When I took it to Boehringer-Mannheim, they were actually clueless.